EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Short-Term Changes in Hematologic Inflammatory Indices During Exenatide Therapy in Patients with Type 2 Diabetes Mellitus

Cigdem Cindoglu, Hüseyin Karaaslan, Nida Uyar, Ali Gökçe, Burcu Dikeç Gökçe, Mehmet Ali Eren

ASIDE Internal Medicine · 08.04.2026 · 3 (2) · 20-25

DOI: 10.71079/aside.im.040826358 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ASIDE Internal Medicine, online erschienen am 08.04.2026. Verfasst von Cigdem Cindoglu und 5 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammation plays an important role in the pathogenesis of type 2 diabetes mellitus (T2DM) and the development of complications. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used to treat T2DM. Mean platelet volume (MPV), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) are simple biomarkers of inflammation. This study evaluated the effects of six-month exenatide therapy on these parameters.

Methods

This single-center retrospective cohort study evaluated 100 adult patients with type 2 diabetes who initiated exenatide treatment and maintained a stable baseline treatment regimen for 6 months (no medication changes for at least 6 months). Clinical, biochemical, and blood count parameters were compared at the start of treatment (month 0) and at months 3 and 6.

Results

At the start of treatment, patients' weight decreased from 111.1±24.4 kg to 104.7±20.8 kg after 6 months (p

Zitieren

APA

Cindoglu, C., Karaaslan, H., Uyar, N., Gökçe, A., Gökçe, B. D., & Eren, M. A. (2026). Short-Term Changes in Hematologic Inflammatory Indices During Exenatide Therapy in Patients with Type 2 Diabetes Mellitus. ASIDE Internal Medicine, 3(2), 20-25. https://doi.org/10.71079/aside.im.040826358

Vancouver

Cindoglu C, Karaaslan H, Uyar N, Gökçe A, Gökçe BD, Eren MA. Short-Term Changes in Hematologic Inflammatory Indices During Exenatide Therapy in Patients with Type 2 Diabetes Mellitus. ASIDE Internal Medicine. 2026;3(2):20-25. doi:10.71079/aside.im.040826358

BibTeX
@article{Cindoglu2026,
  author = {Cindoglu, Cigdem and Karaaslan, Hüseyin and Uyar, Nida and Gökçe, Ali and Gökçe, Burcu Dikeç and Eren, Mehmet Ali},
  title = {Short-Term Changes in Hematologic Inflammatory Indices During Exenatide Therapy in Patients with Type 2 Diabetes Mellitus},
  journal = {ASIDE Internal Medicine},
  year = {2026},
  volume = {3},
  number = {2},
  pages = {20--25},
  doi = {10.71079/aside.im.040826358}
}
Kostenlos starten →